Microport
Microport
Microport mainly engages in medical research and medical equipment production.
MicroPort, established in 1998, is a medical device manufacturer. The company's products cover ten major fields, such as implants, orthopedic medical devices, aortic and puncture vascular intervention products, electrophysiological medical devices and nerve implant products. Founded by Chang Yaohua, it went public on the Hong Kong Stock Exchange. The shareholders are Otsuka, Maxwell Maxcare Science, Shanghai ZJ Hi-Tech Investment, Starwick Investments. Microport's direct competitors include Lepu Medical and Weigao.
- All
- News
- Analysis
- Research
Briefing Sep 09, 2022 04:12 PM
· Healthcare
Trulive Nets Hundreds of Mns of CNY in pre-Series B Financing Round
Briefing Sep 05, 2022 04:50 PM
· Healthcare
LinkZill Nets Tens of Millions of CNY in pre-Series A+
In-depth
Healthcare
Artificial Intelligence and Interventional Surgical Robots
The evolvement and implementation of artificial intelligence (AI) are dramatically changing the medical landscape, and the potential benefits of using AI in interventional medicine are now also being extensively pursued. The article focuses primarily on advances and challenges in AI applied to interventional surgical robots.
Nov 03, 2022 06:11 PM
Briefing Aug 01, 2022 03:11 PM
· Healthcare
Biomedical Lab Supplies Producer Acumen Bags 100 Mn of CNY in Series A Round
Briefing Jun 24, 2022 11:15 AM
· Healthcare
F-star to be acquired by China biopharmaceutical with USD 161million
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 22, 2021 03:11 PM
Briefing Jun 24, 2022 11:07 AM
· Healthcare
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
Briefing Jun 24, 2022 10:46 AM
· Healthcare
East China medicine "liraglutide" goes to sea
Briefing Jun 23, 2022 06:25 PM
· Healthcare
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Healthcare
Digital Therapeutics Enterprise WonderLab Wins about CNY 100 Mn in a New Funding Round
Mental illness has become an unavoidable social problem, leading to a vast market demand. The rise of digital therapeutics has provided a new treatment approach for mental illness.
Dec 05, 2022 04:43 PM
Briefing Jun 23, 2022 06:24 PM
· Healthcare
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Briefing Jun 23, 2022 10:36 AM
· Healthcare
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Briefing Dec 28, 2021 11:59 PM
· Healthcare
Minimally invasive medicine proposes to spin off minimally invasive brain science and list it independently on the main board of the stock exchange
Insight
Healthcare
15 Companies to Watch in November 2022-Healthcare
Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China's healthcare space in November 2022. And the following is a list of deals that we have selected for you, based on a number of criteria, including the funding amount, the financial backers, and the segments in which the startups operate.
Dec 01, 2022 06:02 PM
Briefing Oct 30, 2021 10:44 AM
· Healthcare
Minimally invasive group investment holding Argus strengthens the multi-dimensional layout of precision medicine in the pan vascular field
Briefing Dec 11, 2020 09:57 PM
· Healthcare
Minimally invasive medical treatment: considering the separation of minimally invasive medical robot and independent listing
See more
Related Companies
